Corcept Therapeutics (CORT) Current Leases (2019 - 2026)

Corcept Therapeutics (CORT) has 8 years of Current Leases data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 65.35% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 65.35% YoY), and the FY2025 full-year result was $1.1 million, up 30.76% from the prior year.
• Current Leases grew to $1.6 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.3 million in Q1 2022 to a low of $44000.0 in Q2 2024.
• A 5-year average of $927588.2 and a median of $984000.0 in 2025 frame the typical range for Current Leases.
• Across the five-year window, Current Leases sank 86.88% in 2023 and soared 2211.36% in 2025, its largest moves.
• Tracing CORT's Current Leases over 5 years: stood at $1.1 million in 2022, then slumped by 86.79% to $151000.0 in 2023, then soared by 449.01% to $829000.0 in 2024, then soared by 30.76% to $1.1 million in 2025, then soared by 50.09% to $1.6 million in 2026.
• Business Quant data shows CORT's Current Leases at $1.6 million in Q1 2026, $1.1 million in Q4 2025, and $1.0 million in Q3 2025.